Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR, et al
The variability may result from genetic differences in the rate of metabolism, biodegradation of the drug in the GI lumen, and/or metabolism of the drug during absorption (in the GI mucosa) and first pass through the liver
neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1 and cathepsin G
Use cystatin C-based eGFR equations for more accurate assessment in older patients with low muscle mass [18]
Male B6.TC mice had fold increases of 4.7, 2.3, and 2.5 in the production of ANA, anti-ApoH and ACLA, respectively, over B6 controls
doi:10.1016/j.clinbiochem.2012.11.021 Kurpad AV